Published in Neuromuscul Disord on December 09, 2011
Correlation between genetic and geographic structure in Europe. Curr Biol (2008) 5.02
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci U S A (2011) 3.48
The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain (2006) 2.98
Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA (2012) 2.45
Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial. Thorax (2010) 2.44
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol (2011) 2.36
Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet (2005) 2.23
Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy. Brain (2014) 2.14
Gamma knife surgery of colorectal brain metastases: a high prescription dose of 25 Gy may improve growth control. World Neurosurg (2012) 2.03
Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome. Clin Cancer Res (2010) 2.01
Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism. Am J Hum Genet (2010) 1.95
Polyneuropathy in type 1 and type 2 diabetes: comparison of nerve conduction studies, thermal perception thresholds and intraepidermal nerve fibre densities. Diabetes Metab Res Rev (2010) 1.54
Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity. Int J Cardiol (2002) 1.53
In vivo animal models for studying brain metastasis: value and limitations. Clin Exp Metastasis (2013) 1.52
[A 90-year-old woman with acute hemiparesis]. Tidsskr Nor Laegeforen (2006) 1.48
Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res (2004) 1.48
Investigation of a pathogenic mtDNA microdeletion reveals a translation-dependent deadenylation decay pathway in human mitochondria. Hum Mol Genet (2003) 1.42
Good outcome in patients with early dietary treatment of GLUT-1 deficiency syndrome: results from a retrospective Norwegian study. Dev Med Child Neurol (2013) 1.40
[A man with progressive spastic paraparesis]. Tidsskr Nor Laegeforen (2007) 1.39
Gamma knife surgery in brain melanomas: absence of extracranial metastases and tumor volume strongest indicators of prolonged survival. World Neurosurg (2011) 1.38
Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Clin Cancer Res (2008) 1.36
A reproducible brain tumour model established from human glioblastoma biopsies. BMC Cancer (2009) 1.35
Risk of developing a mitochondrial DNA deletion disorder. Lancet (2004) 1.34
A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion. Neuromuscul Disord (2009) 1.34
New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol (2013) 1.26
OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules. Hum Mol Genet (2010) 1.22
In vivo models of primary brain tumors: pitfalls and perspectives. Neuro Oncol (2012) 1.21
Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess. Am J Pathol (2007) 1.16
Abundance of the POLG disease mutations in Europe, Australia, New Zealand, and the United States explained by single ancient European founders. Eur J Hum Genet (2007) 1.16
MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing. Orphanet J Rare Dis (2013) 1.16
iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype. Mol Cell Proteomics (2009) 1.14
Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes. Brain (2010) 1.14
EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Acta Neuropathol (2013) 1.13
POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain (2008) 1.10
Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma. PLoS One (2011) 1.05
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas. Acta Neuropathol (2014) 1.04
An essential role for tumor necrosis factor in the formation of experimental murine Staphylococcus aureus-induced brain abscess and clearance. J Neuropathol Exp Neurol (2005) 1.04
Muscle biopsies in children--an evaluation of histopathology and clinical value during a 5-year period. Ups J Med Sci (2009) 1.03
Phenotype modulators in myophosphorylase deficiency. Ann Neurol (2003) 1.02
What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr? Brain (2012) 1.01
Prevalence, mutation spectrum and phenotypic variability in Norwegian patients with Limb Girdle Muscular Dystrophy 2I. Neuromuscul Disord (2010) 1.00
Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Stroke (2008) 1.00
Cancer stem cells and angiogenesis. Semin Cancer Biol (2009) 0.99
Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Brain (2013) 0.99
Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild. Mov Disord (2010) 0.99
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer. Breast Cancer Res (2012) 0.98
Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy. PLoS One (2009) 0.96
Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch Neurol (2005) 0.96
Multimodal imaging of neural progenitor cell fate in rodents. Mol Imaging (2008) 0.96
Myasthenia gravis: a review of available treatment approaches. Autoimmune Dis (2011) 0.95
ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation. Hum Mutat (2013) 0.95
Cellular host responses to gliomas. PLoS One (2012) 0.95
Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. J Nucl Med (2009) 0.94
[11C]-L-methionine positron emission tomography in the management of children and young adults with brain tumors. J Neurooncol (2009) 0.94
Progressive striatal necrosis associated with anti-NMDA receptor antibodies. BMC Neurol (2013) 0.93
A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1. PLoS One (2013) 0.93
A novel mitochondrial ND5 (MTND5) gene mutation giving isolated exercise intolerance. Neuromuscul Disord (2008) 0.91
Novel SACS mutations identified by whole exome sequencing in a norwegian family with autosomal recessive spastic ataxia of Charlevoix-Saguenay. PLoS One (2013) 0.91
NUMB does not impair growth and differentiation status of experimental gliomas. Exp Cell Res (2011) 0.90
Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDH1R132 mutation effects in human glioblastoma. J Histochem Cytochem (2011) 0.90
Fukutin-related protein resides in the Golgi cisternae of skeletal muscle fibres and forms disulfide-linked homodimers via an N-terminal interaction. PLoS One (2011) 0.89
Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers. J Histochem Cytochem (2011) 0.89
Molecular dysfunction associated with the human mitochondrial 3302A>G mutation in the MTTL1 (mt-tRNALeu(UUR)) gene. Nucleic Acids Res (2006) 0.87
Oncolytic herpes simplex virus type-1 therapy in a highly infiltrative animal model of human glioblastoma. Clin Cancer Res (2008) 0.87
Leukoencephalopathy with brainstem and spinal cord involvement caused by a novel mutation in the DARS2 gene. J Neurol (2011) 0.87
Myasthenia gravis in individuals over 40. Ann N Y Acad Sci (2003) 0.86
Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI. J Nucl Med (2012) 0.86
8-year-old child with a lesion in the left nucleus lentiformis. Brain Pathol (2008) 0.86
Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy. Biochim Biophys Acta (2010) 0.86
A multicenter study on Leigh syndrome: disease course and predictors of survival. Orphanet J Rare Dis (2014) 0.85
Quantitative measurement of muscle fiber composition in a normal population. Muscle Nerve (2003) 0.85
Molecular pathogenesis of polymerase γ-related neurodegeneration. Ann Neurol (2014) 0.85
Ataxia in mitochondrial disorders. Handb Clin Neurol (2012) 0.85
Palatal tremor and facial dyskinesia in a patient with POLG1 mutation. Mov Disord (2008) 0.85
Acute mitochondrial encephalopathy reflects neuronal energy failure irrespective of which genome the genetic defect affects. Brain (2012) 0.84
Low grade gliomas in eloquent locations - implications for surgical strategy, survival and long term quality of life. PLoS One (2012) 0.84
Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol (2002) 0.84
A novel point mutation in the mitochondrial tRNA(Trp) gene produces a neurogastrointestinal syndrome. Eur J Hum Genet (2004) 0.84
Regulation of the inflammatory response to Staphylococcus aureus-induced brain abscess by interleukin-10. J Neuropathol Exp Neurol (2005) 0.83
A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene. J Neurol (2013) 0.83
Small nerve fiber involvement in systemic lupus erythematosus: a controlled study. Arthritis Rheum (2002) 0.83
Interleukin-10 promoter polymorphisms in myasthenia gravis. J Neuroimmunol (2009) 0.82
Surgical strategy in grade II astrocytoma: a population-based analysis of survival and morbidity with a strategy of early resection as compared to watchful waiting. Acta Neurochir (Wien) (2013) 0.82
CD4 T cells mediate axonal damage and spinal cord motor neuron apoptosis in murine p0106-125-induced experimental autoimmune neuritis. Am J Pathol (2008) 0.82
Expansive growth of two glioblastoma stem-like cell lines is mediated by bFGF and not by EGF. Radiol Oncol (2013) 0.81
CRMP5 antibodies in patients with small-cell lung cancer or thymoma. Cancer Immunol Immunother (2007) 0.81
Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour. Eur J Endocrinol (2012) 0.80
Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family. APMIS (2005) 0.80
Protective immunosurveillance of the central nervous system by Listeria-specific CD4 and CD8 T cells in systemic listeriosis in the absence of intracerebral Listeria. J Immunol (2002) 0.79
Melas associated with mutations in the polg1 gene. Neurology (2008) 0.79
A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells. J Gene Med (2007) 0.79
Hereditary spastic paraplegia caused by the novel mutation 1047insC in the SPG7 gene. J Neurol (2008) 0.79
Neuropathological changes in the brain of pigs with acute liver failure. Scand J Gastroenterol (2010) 0.79
Developmental potential of the murine embryonic stem cells transplanted into the healthy rat brain--novel insights into tumorigenesis. Cell Physiol Biochem (2009) 0.78
Variation of serum creatine kinase (CK) levels and prevalence of persistent hyperCKemia in a Norwegian normal population. The Tromsø Study. Neuromuscul Disord (2011) 0.78